Hadas Cohen-Dvashi, Ph.D. - Publications

Affiliations: 
2011 Weizmann Institute of Science, Rehovot, Israel 
Area:
Cell Biology, Oncology, Neuroscience Biology

9 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Cohen-Dvashi H, Cohen N, Israeli H, Diskin R. Molecular Mechanism for LAMP1 Recognition by Lassa Virus. Journal of Virology. 89: 7584-92. PMID 25972533 DOI: 10.1128/Jvi.00651-15  0.32
2015 Kedmi M, Ben-Chetrit N, Körner C, Mancini M, Ben-Moshe NB, Lauriola M, Lavi S, Biagioni F, Carvalho S, Cohen-Dvashi H, Schmitt F, Wiemann S, Blandino G, Yarden Y. EGF induces microRNAs that target suppressors of cell migration: miR-15b targets MTSS1 in breast cancer. Science Signaling. 8: ra29. PMID 25783158 DOI: 10.1126/Scisignal.2005866  0.36
2015 Cohen-Dvashi H, Ben-Chetrit N, Russell R, Carvalho S, Lauriola M, Nisani S, Mancini M, Nataraj N, Kedmi M, Roth L, Köstler W, Zeisel A, Yitzhaky A, Zylberg J, Tarcic G, et al. Navigator-3, a modulator of cell migration, may act as a suppressor of breast cancer progression. Embo Molecular Medicine. 7: 299-314. PMID 25678558 DOI: 10.15252/Emmm.201404134  0.32
2015 Ben-Chetrit N, Chetrit D, Russell R, Körner C, Mancini M, Abdul-Hai A, Itkin T, Carvalho S, Cohen-Dvashi H, Koestler WJ, Shukla K, Lindzen M, Kedmi M, Lauriola M, Shulman Z, et al. Synaptojanin 2 is a druggable mediator of metastasis and the gene is overexpressed and amplified in breast cancer. Science Signaling. 8: ra7. PMID 25605973 DOI: 10.1126/Scisignal.2005537  0.32
2014 Lauriola M, Enuka Y, Zeisel A, D'Uva G, Roth L, Sharon-Sevilla M, Lindzen M, Sharma K, Nevo N, Feldman M, Carvalho S, Cohen-Dvashi H, Kedmi M, Ben-Chetrit N, Chen A, et al. Diurnal suppression of EGFR signalling by glucocorticoids and implications for tumour progression and treatment. Nature Communications. 5: 5073. PMID 25278152 DOI: 10.1038/Ncomms6073  0.32
2013 Köstler WJ, Zeisel A, Körner C, Tsai JM, Jacob-Hirsch J, Ben-Chetrit N, Sharma K, Cohen-Dvashi H, Yitzhaky A, Lader E, Tschulena U, Rechavi G, Domany E, Wiemann S, Yarden Y. Epidermal growth-factor-induced transcript isoform variation drives mammary cell migration. Plos One. 8: e80566. PMID 24324612 DOI: 10.1371/Journal.Pone.0080566  0.36
2013 Ferraro DA, Gaborit N, Maron R, Cohen-Dvashi H, Porat Z, Pareja F, Lavi S, Lindzen M, Ben-Chetrit N, Sela M, Yarden Y. Inhibition of triple-negative breast cancer models by combinations of antibodies to EGFR Proceedings of the National Academy of Sciences of the United States of America. 110: 1815-1820. PMID 23319610 DOI: 10.1073/Pnas.1220763110  0.32
2013 Zeisel A, Yitzhaky A, Koerner C, Lauriola M, Cohen-Dvashi H, Köstler WJ, Yarden Y, Wiemann S, Domany E. qCMA: a desktop application for quantitative collective cell migration analysis. Journal of Biomolecular Screening. 18: 356-60. PMID 23042078 DOI: 10.1177/1087057112461940  0.36
2012 Pareja F, Ferraro DA, Rubin C, Cohen-Dvashi H, Zhang F, Aulmann S, Ben-Chetrit N, Pines G, Navon R, Crosetto N, Köstler W, Carvalho S, Lavi S, Schmitt F, Dikic I, et al. Deubiquitination of EGFR by Cezanne-1 contributes to cancer progression. Oncogene. 31: 4599-608. PMID 22179831 DOI: 10.1038/Onc.2011.587  0.32
Show low-probability matches.